TY - CHAP A1 - Hitomi Fujie A2 - Muneo Numasaki ED1 - Hilal Arnouk Y1 - 2012-02-03 PY - 2012 T1 - Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy N2 - Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses. BT - Advancements in Tumor Immunotherapy and Cancer Vaccines SP - Ch. 9 UR - https://doi.org/10.5772/28436 DO - 10.5772/28436 SN - PB - IntechOpen CY - Rijeka Y2 - 2021-05-13 ER -